Publication | Closed Access

Elevated asymmetric dimethylarginine in plasma: An early marker for endothelial dysfunction in non-alcoholic fatty liver disease?

PathologyFatty Liver DiseaseObesityMetabolic SyndromeMetabolic Associated Steatotic Liver DiseaseNonalcoholic Fatty Liver DiseaseAtherosclerosisDyslipidemiaEarly MarkerHealth SciencesLiver PhysiologyVascular BiologyPharmacologyHepatologyCardiovascular DiseaseEndothelial DysfunctionLiver DiseaseMedicineAsymmetric Dimethylarginine